TLR9 and rheumatoid arthritis: 2.4. TLR9 Inhibition Decreases the Numbers of Double-Positive IL-17A+/IFN-γ+, Double-Positive IL-17A+/FOXP3+, and Triple-Positive IL-17A+/IFN-γ+/FOXP3+ Foci in an EBV DNA-Exacerbated RA Mouse Model